Aureus Asset Management’s Integra LifeSciences IART Stock Holding History

Aureus Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,000	Closed	-$280K	–	175
2017 Q1	$280K	Hold	6,000	–	–	0.05%	140
2016 Q4	$257K	Hold	6,000	–	–	0.05%	127
2016 Q3	$248K	Hold	6,000	–	–	0.05%	127
2016 Q2	$239K	Buy	+6,000	New	+$216K	0.05%	111
2016 Q1	–	Sell	-6,000	Closed	-$203K	–	123
2015 Q4	$203K	Buy	+6,000	New	+$188K	0.05%	140

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aureus Asset Management's IART Position: Q2 2017 in Review

Aureus Asset Management sold out of Integra LifeSciences (IART) in Q2 2017, closing a stake of 6,000 shares — an estimated $280K sold.

Aureus Asset Management first reported a position in IART in Q4 2015 and held it in 5 quarters. The position peaked at $280K in Q1 2017. 223 funds tracked by Wall St. Rank hold IART as of Q2 2017.

Aureus Asset Management reported no remaining Integra LifeSciences position as of Q2 2017 after selling out during the quarter.
Aureus Asset Management sold 6,000 Integra LifeSciences shares in Q2 2017, an estimated $280K.
Aureus Asset Management first reported a position in Integra LifeSciences in Q4 2015 and held it in 5 quarters.
Aureus Asset Management's Integra LifeSciences position peaked at $280K in Q1 2017.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2017.

Based on Aureus Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.